Package 0363-0077-36

{"route": ["ORAL"], "spl_id": "23bd928b-a15a-4da4-80c3-c599113f8376", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ", "6V9V2RYJ8N"], "rxcui": ["1305603"], "spl_set_id": ["310d14be-e7ea-44b8-8b04-cffa39440d50"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["WALGREEN COMPANY"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (0363-0077-18)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0363-0077-18", "marketing_start_date": "20170801"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (0363-0077-36)  / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0363-0077-36", "marketing_start_date": "20170801"}], "brand_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "product_id": "0363-0077_23bd928b-a15a-4da4-80c3-c599113f8376", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "0363-0077", "generic_name": "Guaifenesin and Pseudoephedrine Hydrochloride", "labeler_name": "WALGREEN COMPANY", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Pseudoephedrine Hydrochloride", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "NDA021585", "marketing_category": "NDA", "marketing_start_date": "20170801", "listing_expiration_date": "20261231"}